July 18, 2023
Manufacturer Danaher Corp. has been hit with a proposed investor class action alleging it failed to prepare its shareholders for a falloff in revenue it was poised to see as COVID-19 case numbers eased and the company's diagnostic tests and life sciences segments saw less business related to PCR testing, vaccines and therapy development.